Both in Pharmaceuticals
SELLAS Life Sciences Group vs Precigen
Over the past year SLS returned +419.0% and PGEN returned +49.8%; their daily moves had a correlation of 0.24.
SLS +419.0% PGEN +49.8%Growth of $1, one year, split-adjusted
| Metric | SLS | PGEN |
|---|---|---|
| Price | $10.38 | $6.08 |
| Market cap | $2.10B | $2.18B |
| Today | −14.71% | −1.14% |
| 1 month | −9.8% | −24.5% |
| 6 months | +122.3% | +47.6% |
| Year to date | +175.3% | +45.5% |
| 1 year | +435.1% | +41.4% |
| Revenue growth (YoY) | — | +6322.7% |
| Gross margin | — | 94.9% |
| Net margin | — | 36.5% |
| P/E (TTM) | — | — |
| Price / sales | — | 25.4× |
| Net cash | $138.3M | -$55.7M |
| Dividend yield | — | — |
| Volatility (60d) | 94.4% | 59.9% |
| Short % of float | 27.0% | 26.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).